WallStreetZenWallStreetZen

NYSE: BIO
Bio Rad Laboratories Revenue

Bio Rad Laboratories revenue was $2.58B for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $649.7M, up 1.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, BIO annual revenue was $2.7B, with -4.7% growth year-over-year.

BIO past revenue growth

How has BIO's revenue growth performed historically?
Company
-5.15%
Industry
10.98%
Market
39.93%
BIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BIO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BIO revenue history

Current Revenue
$2.6B
Current Earnings
-$778.7M
Current Profit Margin
-30.2%

Be the first to know when BIO announces revenue.

BIO Revenue History By Year

BIO Yearly RevenueBIO RevenueBIO ChangeBIO Revenue Growth
2023-12-31$2.67B-$130.99M-4.67%
2022-12-31$2.80B-$120.30M-4.12%
2021-12-31$2.92B$376.92M+14.81%
2020-12-31$2.55B$233.97M+10.12%
2019-12-31$2.31B$22.24M+0.97%
2018-12-31$2.29B$129.26M+5.98%
2017-12-31$2.16B$91.98M+4.45%
2016-12-31$2.07B$48.73M+2.41%
2015-12-31$2.02B-$155.60M-7.15%
2014-12-31$2.18B$42.35M+1.99%
2013-12-31$2.13B$63.46M+3.07%
2012-12-31$2.07B-$4.29M-0.21%
2011-12-31$2.07B$146.41M+7.60%
2010-12-31$1.93B$142.87M+8.01%
2009-12-31$1.78B$19.88M+1.13%
2008-12-31$1.76B$303.31M+20.76%
2007-12-31$1.46B$187.12M+14.69%
2006-12-31$1.27B$92.95M+7.87%
2005-12-31$1.18B$90.97M+8.35%
2004-12-31$1.09B$110.38M+11.27%
2003-12-31$979.63M$114.63M+13.25%
2002-12-31$865.01M$47.50M+5.81%
2001-12-31$817.51M$91.63M+12.62%
2000-12-31$725.88M$170.49M+30.70%
1999-12-31$555.40M$107.54M+24.01%
1998-12-31$447.86M$20.95M+4.91%
1997-12-31$426.91M$8.13M+1.94%
1996-12-31$418.79M$22.17M+5.59%
1995-12-31$396.62M$41.32M+11.63%
1994-12-31$355.30MN/AN/A

1 of 2

Bio Rad Laboratories Revenue FAQ

What was BIO's revenue last quarter?

On Invalid Date, Bio Rad Laboratories (NYSE: BIO) reported Q3 2024 revenue of $649.73 million up 2.79% year over year. In the same quarter last year, Bio Rad Laboratories's revenue was $632.12 million.

What was Bio Rad Laboratories's revenue in 2023?

Bio Rad Laboratories's annual revenue for the twelve months ending Dec 31, 2023 was $2.67 billion, a 4.67% decrease year over year.

How much does Bio Rad Laboratories make in a day?

Based on Bio Rad Laboratories annual revenue for the past five years, BIO makes an average of $7,262,104.66 per day.

What was Bio Rad Laboratories's annual revenue growth in the past year?

As of Q4 2024, Bio Rad Laboratories's revenue has grown -5.15% year over year. This is 16.13 percentage points lower than the US Medical Devices industry revenue growth rate of 10.98%. Bio Rad Laboratories's revenue in the past year totaled $2.58 billion.

How much does Bio Rad Laboratories make in a year?

Bio Rad Laboratories's revenue by year for the past five years is:
  • Bio Rad Laboratories's revenue for the twelve months ending Dec 31, 2023 was $2.67 billion, a 4.67% decrease year over year.
  • Bio Rad Laboratories's annual revenue for Dec 31, 2022 was $2.80 billion, a 4.12% decrease from 2021.
  • Bio Rad Laboratories's annual revenue for 2021 was $2.92 billion, a 14.81% increase from 2020.
  • Bio Rad Laboratories's annual revenue for 2020 was $2.55 billion, a 10.12% increase from 2019.
  • Bio Rad Laboratories's annual revenue for 2019 was $2.31 billion, a 0.97% increase from 2018.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.